Coloplast A/S (OTCMKTS:CLPBY) Raised to Strong-Buy at Kepler Capital Markets

Coloplast A/S (OTCMKTS:CLPBY) was upgraded by equities researchers at Kepler Capital Markets to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports.

A number of other research analysts have also recently commented on CLPBY. Sanford C. Bernstein raised Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Coloplast A/S Trading Up 2.6%

Shares of CLPBY stock opened at $6.62 on Wednesday. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The firm has a market cap of $14.91 billion, a P/E ratio of 47.26, a PEG ratio of 2.04 and a beta of 0.15. The company has a 50 day moving average of $6.61 and a 200-day moving average of $7.83. Coloplast A/S has a 12-month low of $6.10 and a 12-month high of $10.03.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%.The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.11 billion. Sell-side analysts anticipate that Coloplast A/S will post 0.4 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.